RadioPublic is Helping Podcast Fans Discover New and Exciting Content
Traditional radio is declining, while consumers can't get enough of podcasts. According to some reports, about 67 million Americans listen to podcasts each month. RadioPublic is a space where podcast fans can discover and curate their favorite podcasts.
Jake Shapiro is the CEO and Co-founder of RadioPublic. He joins Cheddar to explain how their start-up is grabbing a portion of the podcast market.
Shapiro explains that people still enjoy podcasts because on platforms like RadioPublic consumers get on-demand content. RadioPublic recently announced a Paid Listens program to help support their podcast creators.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.